Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2402

1.

Mortality After Repeat Revascularization Following PCI or Coronary Artery Bypass Grafting for Left Main Disease: The EXCEL Trial.

Giustino G, Serruys PW, Sabik JF 3rd, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M 3rd, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW.

JACC Cardiovasc Interv. 2020 Jan 10. pii: S1936-8798(19)31972-7. doi: 10.1016/j.jcin.2019.09.019. [Epub ahead of print]

PMID:
31954680
2.

Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies.

Stegehuis VE, Wijntjens GWM, Bax M, Meuwissen M, Chamuleau SAJ, Voskuil M, Koch KT, Di Mario C, Vrints C, Haude M, Board ES, Serruys PW, Piek JJ, van de Hoef TP.

EuroIntervention. 2020 Jan 21. pii: EIJ-D-19-00774. doi: 10.4244/EIJ-D-19-00774. [Epub ahead of print]

3.

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.

Tomaniak M, Chichareon P, Klimczak-Tomaniak D, Takahashi K, Kogame N, Modolo R, Wang R, Ono M, Hara H, Gao C, Kawashima H, Rademaker-Havinga T, Garg S, Curzen N, Haude M, Kochman J, Gori T, Montalescot G, Angiolillo DJ, Capodanno D, Storey RF, Hamm C, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Serruys PW, Anderson R.

Clin Res Cardiol. 2020 Jan 10. doi: 10.1007/s00392-019-01586-9. [Epub ahead of print]

PMID:
31925529
4.

Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.

Onuma Y, Honda Y, Asano T, Shiomi H, Kozuma K, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Hanaoka KI, Tanabe K, Okada K, Kitahara H, Ono M, Kusano H, Rapoza R, Simonton C, Popma JJ, Stone GW, Fitzgerald PJ, Serruys PW, Kimura T.

JACC Cardiovasc Interv. 2020 Jan 13;13(1):116-127. doi: 10.1016/j.jcin.2019.09.047.

5.

The year in cardiology: coronary interventions.

Baumbach A, Bourantas CV, Serruys PW, Wijns W.

Eur Heart J. 2020 Jan 14;41(3):394-405. doi: 10.1093/eurheartj/ehz947. No abstract available.

PMID:
31901934
6.

The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy.

Tijssen RYG, Kerkmeijer LSM, Takahashi K, Kogame N, Katagiri Y, Kraak RP, Chichareon P, Modolo R, Asano T, Nassif M, Kalkman DN, Sotomi Y, Collet C, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Piek JJ, Tijssen JGP, Henriques JP, de Winter RJ, Onuma Y, Serruys PW, Wykrzykowska JJ.

Int J Cardiovasc Imaging. 2020 Jan 2. doi: 10.1007/s10554-019-01756-w. [Epub ahead of print]

PMID:
31898006
7.

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial.

Tomaniak M, Chichareon P, Takahashi K, Kogame N, Modolo R, Chang CC, Spitzer E, Neumann FJ, Plante S, Hernández Antolin R, Jambrik Z, Gelev V, Brunel P, Konteva M, Beygui F, Morelle JF, Filipiak KJ, van Geuns RJ, Soliman O, Tijssen J, Rademaker-Havinga T, Storey RF, Hamm C, Steg PG, Windecker S, Onuma Y, Valgimigli M, Serruys PW.

Eur Heart J Cardiovasc Pharmacother. 2019 Dec 9. pii: pvz052. doi: 10.1093/ehjcvp/pvz052. [Epub ahead of print]

PMID:
31876907
8.

Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.

Kogame N, Serruys PW, Onuma Y.

Eur Heart J. 2019 Dec 23. pii: ehz876. doi: 10.1093/eurheartj/ehz876. [Epub ahead of print] No abstract available.

PMID:
31872236
9.

Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.

Garg S, Chichareon P, Kogame N, Takahashi K, Modolo R, Chang CC, Tomaniak M, Fath-Ordoubadi F, Anderson R, Oldroyd KG, Stables RH, Kukreja N, Chowdhary S, Galasko G, Hoole S, Zaman A, Hamm CW, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Serruys PW.

Catheter Cardiovasc Interv. 2019 Dec 19. doi: 10.1002/ccd.28649. [Epub ahead of print]

PMID:
31854112
10.

Very long-term outcome of ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier À, Buono A, Serruys PW, Sabaté M; Collaborators.

EuroIntervention. 2019 Dec 17. pii: EIJ-D-19-00773. doi: 10.4244/EIJ-D-19-00773. [Epub ahead of print]

11.

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial.

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang CC, Kogame N, Spitzer E, Buszman PE, van Geuns RM, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen JGP, Jüni P, Hamm C, Steg PG, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys PW.

EuroIntervention. 2019 Dec 17. pii: EIJ-D-19-00699. doi: 10.4244/EIJ-D-19-00699. [Epub ahead of print]

12.

Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study.

Chang CC, Chichareon P, Modolo R, Takahashi K, Kogame N, Tomaniak M, Gao C, Royaards KJ, Cequier A, Oldroyd K, Steg PG, Hamm C, Jüni P, Valgimigli M, Windecker S, Onuma Y, Stables RH, Jan van Geuns R, Serruys PW.

Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):22-30. doi: 10.1093/ehjcvp/pvz051.

PMID:
31841136
13.

Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION Trial.

Andreini D, Modolo R, Katagiri Y, Mushtaq S, Sonck J, Collet C, De Martini S, Roberto M, Tanaka K, Miyazaki Y, Czapla J, Schoors D, Plass A, Maisano F, Kaufmann P, Orry X, Metzdorf PA, Folliguet T, Färber G, Diamantis I, Schönweiß M, Bonalumi G, Guglielmo M, Ferrari C, Olivares P, Cavallotti L, Leal I, Lindeboom W, Onuma Y, Serruys PW, Bartorelli AL; SYNTAX III REVOLUTION Investigators.

Circ Cardiovasc Interv. 2019 Dec;12(12):e007607. doi: 10.1161/CIRCINTERVENTIONS.118.007607. Epub 2019 Dec 13.

PMID:
31833413
14.

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial.

Takahashi K, Kogame N, Tomaniak M, Chichareon P, Chang CC, Modolo R, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Buszman P, Bolognese L, Tumscitz C, Żmudka K, Aminian A, Vrolix M, Petrov I, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Onuma Y, Valgimigli M, Windecker S, Vranckx P, Garg S, Serruys PW.

Clin Res Cardiol. 2019 Dec 11. doi: 10.1007/s00392-019-01585-w. [Epub ahead of print]

PMID:
31828504
15.

Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.

Kosmidou I, Liu Y, Zhang Z, Redfors B, Kappetein AP, Serruys PW, Gersh BJ, Kandzari DE, Morice MC, Buszman PE, Bochenek A, Schampaert E, Sabik JF 3rd, Ben-Yehuda O, Stone GW.

Am J Cardiol. 2019 Nov 19. pii: S0002-9149(19)31315-3. doi: 10.1016/j.amjcard.2019.11.021. [Epub ahead of print]

PMID:
31813531
16.

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial.

Kandzari DE, Gershlick AH, Serruys PW, Leon MB, Morice MC, Simonton CA, Lembo NJ, Mansour S, Sabaté M, Sabik JF 3rd, Kappetein AP, Dressler O, Stone GW.

EuroIntervention. 2019 Dec 3. pii: EIJ-D-19-00686. doi: 10.4244/EIJ-D-19-00686. [Epub ahead of print]

17.

Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial.

Kini AS, Dangas GD, Baber U, Vengrenyuk Y, Kandzari DE, Leon MB, Morice MC, Serruys PW, Kappetein AP, Sabik JF 3rd, Dressler O, Mehran R, Sharma SK, Stone GW.

EuroIntervention. 2019 Nov 26. pii: EIJ-D-19-00851. doi: 10.4244/EIJ-D-19-00851. [Epub ahead of print]

18.

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.

Chichareon P, Modolo R, Collet C, Tenekecioglu E, Vink MA, Oh PC, Ahn JM, Musto C, Díaz de la Llera LS, Cho YS, Violini R, Park SJ, Suryapranata H, Piek JJ, de Winter RJ, Wykrzykowska JJ, Spaulding C, Kang WC, Slagboom T, Hofma SH, Wijnbergen IF, Di Lorenzo E, Pijls NH, Räber L, Brugaletta S, Sabaté M, Stoll HP, Stone GW, Windecker S, Onuma Y, Serruys PW.

J Am Coll Cardiol. 2019 Nov 26;74(21):2572-2584. doi: 10.1016/j.jacc.2019.09.038.

PMID:
31753202
19.

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions.

Kelbæk H, Yeh RW, Engstrøm T, Neumann FJ, Serruys PW, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S.

EuroIntervention. 2019 Nov 19. pii: EIJ-D-19-00866. doi: 10.4244/EIJ-D-19-00866. [Epub ahead of print]

20.

Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique.

Modolo R, Chang CC, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben JP, Rutten MCM, Pighi M, El Bouziani A, van Mourik M, Lemos PA, Wykrzykowska JJ, Brito FS Jr, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem NM, de Winter RJ, Serruys PW.

EuroIntervention. 2019 Nov 19. pii: EIJ-D-19-00879. doi: 10.4244/EIJ-D-19-00879. [Epub ahead of print]

21.

Efficacy and Reproducibility of Attenuation-Compensated Optical Coherence Tomography for Assessing External Elastic Membrane Border and Plaque Composition in Native and Stented Segments - An In Vivo and Histology-Based Study.

Ramasamy A, Ng J, White S, Johnson TW, Foin N, Girard MJA, Dijkstra J, Amersey R, Scoltock S, Koganti S, Jones D, Jin C, Räber L, Serruys PW, Torii R, Crake T, Rakhit R, Baumbach A, Mathur A, Bourantas CV.

Circ J. 2019 Dec 25;84(1):91-100. doi: 10.1253/circj.CJ-19-0630. Epub 2019 Nov 15.

22.

Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial).

Kosmidou I, Crowley A, Macedo L, Ben-Yehuda O, Gersh BJ, Boonstra PW, Kappetein AP, Serruys PW, Sabik JF 3rd, Stone GW.

Am J Cardiol. 2020 Jan 15;125(2):169-175. doi: 10.1016/j.amjcard.2019.10.004. Epub 2019 Oct 26.

PMID:
31735328
23.

Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.

Chichareon P, Modolo R, Kerkmeijer L, Tomaniak M, Kogame N, Takahashi K, Chang CC, Komiyama H, Moccetti T, Talwar S, Colombo A, Maillard L, Barlis P, Wykrzykowska J, Piek JJ, Garg S, Hamm C, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Mehran R, Serruys PW.

JAMA Cardiol. 2019 Nov 6:1-10. doi: 10.1001/jamacardio.2019.4296. [Epub ahead of print]

PMID:
31693078
24.

Optical coherence tomography enables more accurate detection of functionally significant intermediate non-left main coronary artery stenoses than intravascular ultrasound: A meta-analysis of 6919 patients and 7537 lesions.

Ramasamy A, Chen Y, Zanchin T, Jones DA, Rathod K, Jin C, Onuma Y, Zhang YJ, Amersey R, Westwood M, Ozkor M, O'Mahony C, Lansky A, Crake T, Serruys PW, Mathur A, Baumbach A, Bourantas CV.

Int J Cardiol. 2020 Feb 15;301:226-234. doi: 10.1016/j.ijcard.2019.09.067. Epub 2019 Oct 9.

PMID:
31677827
25.

Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry.

Kobayashi T, Sotomi Y, Suzuki S, Hamanaka Y, Nakatani S, Dijkstra J, Onuma Y, Serruys PW, Sakata Y, Hirayama A, Higuchi Y.

Int J Cardiovasc Imaging. 2019 Oct 31. doi: 10.1007/s10554-019-01718-2. [Epub ahead of print]

PMID:
31673850
26.

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Heg D, Jüni P, Windecker S, Valgimigli M; GLASSY Investigators.

J Am Coll Cardiol. 2019 Nov 5;74(18):2223-2234. doi: 10.1016/j.jacc.2019.08.1038.

PMID:
31672177
27.

The obesity paradox revisited: body mass index and -long-term outcomes after PCI from a large pooled patient-level database.

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz GS, Redfors B, Madhavan MV, Smits PC, von Birgelen C, Serruys PW, Mehran R, Leon MB, Stone GW.

EuroIntervention. 2020 Jan 17;15(13):1199-1208. doi: 10.4244/EIJ-D-19-00467.

28.

Reliable in vivo intravascular imaging plaque characterization: A challenge unmet.

Ramasamy A, Serruys PW, Jones DA, Johnson TW, Torii R, Madden SP, Amersey R, Krams R, Baumbach A, Mathur A, Bourantas CV.

Am Heart J. 2019 Dec;218:20-31. doi: 10.1016/j.ahj.2019.07.008. Epub 2019 Jul 23. Review.

PMID:
31655414
29.

The SYNTAX score on its way out or … towards artificial intelligence: part I.

Serruys PW, Chichareon P, Modolo R, Leaman DM, Reiber JHC, Emanuelsson H, Di Mario C, Pijls NHJ, Morel MA, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas CV, Davies J, Banning AP, Escaned J, Piek JJ, Echavarría-Pinto M, Taylor CA, Thomsen B, Collet C, Pompilio G, Bartorelli AL, Glocker B, Dressler O, Stone GW, Onuma Y.

EuroIntervention. 2019 Oct 25. pii: EIJ-D-19-00543A. doi: 10.4244/EIJ-D-19-00543A. [Epub ahead of print] No abstract available.

30.

The SYNTAX score on its way out or … towards artificial intelligence: part II.

Serruys PW, Chichareon P, Modolo R, Leaman DM, Reiber JHC, Emanuelsson H, Di Mario C, Pijls NHJ, Morel MA, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas CV, Davies J, Banning AP, Escaned J, Piek JJ, Echavarría-Pinto M, Taylor CA, Thomsen B, Collet C, Pompilio G, Bartorelli AL, Glocker B, Dressler O, Stone GW, Onuma Y.

EuroIntervention. 2019 Oct 25. pii: EIJ-D-19-00543B. doi: 10.4244/EIJ-D-19-00543B. [Epub ahead of print] No abstract available.

31.

Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial).

Chang CC, Spitzer E, Chichareon P, Takahashi K, Modolo R, Kogame N, Tomaniak M, Komiyama H, Yap SC, Hoole SP, Gori T, Zaman A, Frey B, Ferreira RC, Bertrand OF, Koh TH, Sousa A, Moschovitis A, van Geuns RJ, Steg PG, Hamm C, Jüni P, Vranckx P, Valgimigli M, Windecker S, Serruys PW, Soliman O, Onuma Y.

Am J Cardiol. 2019 Dec 15;124(12):1833-1840. doi: 10.1016/j.amjcard.2019.08.049. Epub 2019 Sep 26.

PMID:
31648781
32.

Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.

Kim CH, Koo BK, Dehbi HM, Lee JM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys PW, Escaned J, Davies JE.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2035-2046. doi: 10.1016/j.jcin.2019.06.035.

PMID:
31648764
33.

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.

Takahashi K, Serruys PW, Chichareon P, Chang CC, Tomaniak M, Modolo R, Kogame N, Magro M, Chowdhary S, Eitel I, Zweiker R, Ong P, Ottesen MM, Tijssen JGP, Wykrzykowska JJ, de Winter RJ, Garg S, Stoll HP, Hamm C, Steg PG, Onuma Y, Valgimigli M, Vranckx P, Carrie D, Windecker S.

J Am Coll Cardiol. 2019 Oct 22;74(16):2015-2027. doi: 10.1016/j.jacc.2019.08.997.

PMID:
31623758
34.

Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy.

Modolo R, Chichareon P, van Klaveren D, Dressler O, Zhang Y, Sabik JF, Onuma Y, Kappetein AP, Stone GW, Serruys PW.

Eur J Cardiothorac Surg. 2019 Oct 16. pii: ezz274. doi: 10.1093/ejcts/ezz274. [Epub ahead of print]

PMID:
31620778
35.

Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.

Garcia-Garcia HM, McFadden EP, von Birgelen C, Rademaker-Havinga T, Spitzer E, Kleiman NS, Cohen DJ, Kennedy KF, Camenzind E, Mauri L, Steg PG, Wijns W, Silber S, van Es GA, Serruys PW, Windecker S, Cutlip D, Vranckx P.

JACC Cardiovasc Interv. 2019 Oct 14;12(19):1954-1962. doi: 10.1016/j.jcin.2019.07.014.

PMID:
31601389
36.

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Tomaniak M, Storey RF, Serruys PW.

EuroIntervention. 2020 Jan 17;15(13):1125-1129. doi: 10.4244/EIJY19M10_01. No abstract available.

37.

The EuroIntervention health check 2019.

Mylotte D, Byrne RA, Capodanno D, Søndergaard L, Vahanian A, Serruys PW.

EuroIntervention. 2019 Oct 4;15(9):e733-e735. doi: 10.4244/EIJV15I9A135. No abstract available.

38.

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease.

Kogame N, Takahashi K, Tomaniak M, Chichareon P, Modolo R, Chang CC, Komiyama H, Katagiri Y, Asano T, Stables R, Fath-Ordoubadi F, Walsh S, Sabaté M, Davies JE, Piek JJ, van Geuns RJ, Reiber JHC, Banning AP, Escaned J, Farooq V, Serruys PW, Onuma Y.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2064-2075. doi: 10.1016/j.jcin.2019.08.009. Epub 2019 Sep 25.

PMID:
31563682
39.

Was the Ball Inside or Outside the Court?: Ask the Hawk-Eye System.

Serruys PW, Kogame N, Onuma Y.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2089-2092. doi: 10.1016/j.jcin.2019.07.001. Epub 2019 Sep 25. No abstract available.

PMID:
31563681
40.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW; EXCEL Trial Investigators.

N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.

PMID:
31562798
41.

Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

Stone GW, Kimura T, Gao R, Kereiakes DJ, Ellis SG, Onuma Y, Chevalier B, Simonton C, Dressler O, Crowley A, Ali ZA, Serruys PW.

JAMA Cardiol. 2019 Sep 27. doi: 10.1001/jamacardio.2019.4101. [Epub ahead of print]

PMID:
31561250
42.

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Tomaniak M, Chichareon P, Onuma Y, Deliargyris EN, Takahashi K, Kogame N, Modolo R, Chang CC, Rademaker-Havinga T, Storey RF, Dangas GD, Bhatt DL, Angiolillo DJ, Hamm C, Valgimigli M, Windecker S, Steg PG, Vranckx P, Serruys PW; GLOBAL LEADERS Trial Investigators.

JAMA Cardiol. 2019 Sep 26. doi: 10.1001/jamacardio.2019.3355. [Epub ahead of print]

PMID:
31557763
43.

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel MA, Serruys PW, Gil RJ.

EuroIntervention. 2019 Sep 24. pii: EIJ-D-19-00361. doi: 10.4244/EIJ-D-19-00361. [Epub ahead of print]

44.

Sex differences in clinical outcomes following bioresorbable scaffold implantation: a paradigm shift?

Bourantas CV, Bajaj R, Tufaro V, Kilic Y, Serruys PW.

EuroIntervention. 2019 Sep 20;15(7):574-576. doi: 10.4244/EIJV15I7A105. No abstract available.

45.

Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review.

Chang CC, Veen KM, Hahn RT, Bogers AJJC, Latib A, Oei FBS, Abdelghani M, Modolo R, Ho SY, Abdel-Wahab M, Fattouch K, Bosmans J, Caliskan K, Taramasso M, Serruys PW, Bax JJ, van Mieghem NMDA, Takkenberg JJM, Lurz P, Modine T, Soliman O.

Eur Heart J. 2019 Sep 11. pii: ehz614. doi: 10.1093/eurheartj/ehz614. [Epub ahead of print]

PMID:
31511897
46.

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial.

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang CC, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen JGP, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Stoll HP, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Sep 10. pii: EIJ-D-19-00498. doi: 10.4244/EIJ-D-19-00498. [Epub ahead of print]

47.

Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.

Shlofmitz E, Généreux P, Chen S, Dressler O, Ben-Yehuda O, Morice MC, Puskas JD, Taggart DP, Kandzari DE, Crowley A, Redfors B, Mehdipoor G, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW.

Circ Cardiovasc Interv. 2019 Sep;12(9):e008007. doi: 10.1161/CIRCINTERVENTIONS.118.008007. Epub 2019 Sep 9.

PMID:
31495220
48.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR Jr, Curzen N, Davierwala P, Noack T, Milojevic M, Dawkins KD, da Costa BR, Jüni P, Head SJ; SYNTAX Extended Survival Investigators.

Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.

PMID:
31488373
49.

Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.

Søndergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstrøm T; SURTAVI Trial Investigators.

Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.118.039564. [Epub ahead of print]

PMID:
31476897
50.

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.

Chang CC, Kogame N, Onuma Y, Byrne RA, Capodanno D, Windecker S, Morel MA, Cutlip DE, Krucoff MW, Stone GW, Lansky AJ, Mehran R, Spitzer E, Fraser AG, Baumbach A, Serruys PW.

EuroIntervention. 2020 Jan 17;15(13):1190-1198. doi: 10.4244/EIJ-D-19-00552.

Supplemental Content

Loading ...
Support Center